Application value of transcranial ultrasound in evaluating the third ventricle in Parkinson's disease complicated with cognitive impairment
10.3760/cma.j.issn.0254-9026.2025.06.016
- VernacularTitle:经颅超声评估第三脑室在帕金森病合并认知障碍的应用价值
- Author:
Cuiping WANG
1
;
Wen SU
;
Junhong REN
Author Information
1. 北京医院超声科 国家老年医学中心 中国医学科学院老年医学研究院，北京 100730
- Publication Type:Journal Article
- Keywords:
Parkinson's disease;
Cognition;
Transcranial ultrasonography
- From:
Chinese Journal of Geriatrics
2025;44(6):766-771
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the application value of transcranial ultrasound(TCS)in evaluating the third ventricle in cognitive impairment associated with Parkinson's disease(PD).Methods:A cross-sectional study was conducted.A total of 100 patients with PD, hospitalized and diagnosed in the Department of Neurology at Beijing Hospital from January 2021 to May 2024, were included in the study.Due to limitations related to the temporal window, the third ventricle could not be visualized in 2 patients(2%).Consequently, a total of 98 PD patients underwent TCS and cranial magnetic resonance imaging(MRI)examinations.Based on the Montreal Cognitive Assessment(MoCA)score, the PD patients were classified into three groups: normal cognitive function(18 cases), mild to moderate cognitive impairment(62 cases), and severe cognitive impairment(18 cases).The clinical manifestations and ultrasonic image characteristics of patients in each group were compared.Results:TCS and MRI demonstrate strong consistency in measuring the width of the third ventricle, with an intraclass correlation coefficient(ICC)of 0.783.Patients with severe cognitive impairment exhibit a wider third ventricle compared to those with normal cognitive function( P=0.002), and the width in patients with severe cognitive impairment is also greater than that in patients with moderate cognitive impairment( P=0.016).Additionally, the width of the third ventricle in individuals with PD shows a positive correlation with age( P<0.001), but it does not correlate with disease duration, the area of substantia nigra hyperecho, midbrain area, MoCA scores, Mini-Mental State Examination(MMSE)scores, Hamilton Anxiety Rating Scale(HAMA)scores, or Hamilton Depression Rating Scale(HAMD)scores( P>0.05).No statistically significant difference was found in the area of bilateral substantia nigra hyperecho among the three groups( P>0.05).Multiple linear regression analysis indicated that disease duration, third ventricle width, midbrain area, HAMD, and HAMA do not affect MoCA( P>0.05), while MMSE scores have a statistically significant impact on MoCA( P<0.001). Conclusions:The measurement of the third ventricle using TCS is valuable for evaluating cognitive decline.In patients with PD who exhibit severe cognitive impairment, the third ventricle is often widened; however, the width of the third ventricle does not correlate with cognitive performance.
